Clinical Trial Update: A Trial of Pulse Dyed Laser (Chromogenex Regenlite Transform) in the Treatment of Inflammatory Acne Vulgaris [Phase 4]

View source ↗

Summary

Phase 4 clinical trial evaluating a Pulse Dye Laser (Chromogenex Regenlite Transform) for inflammatory acne vulgaris has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acne Vulgaris

Drugs mentioned

• Pulse Dye Laser (Chromogenex Regenlite Transform)

Snippet

Sponsor: Sadick Research Group | Conditions: Acne Vulgaris | Phase 4 | Status: WITHDRAWN